Article

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocol

2026-01-05

Abstract excerpt

<h4>Introduction: </h4> Discontinuation of psychotropic medication is associated with considerable clinical challenges, including withdrawal symptoms and relapse. Pharmacogenomic testing is increasingly used in clinical practice to optimise pharmacotherapy by guiding drug selection and dosing, however, its role in informing medication discontinuation and tapering strategies remains underexplored. Understanding the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0819741a-9c7a-53cb-b8d5-71e7fe21e749
DOI: 10.12688/hrbopenres.14314.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocolDOI 10.12688/hrbopenres.14314.1Read

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocolSemantic proximity Read

Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population.Semantic proximity Read

Trials evaluating drug discontinuation: a scoping review sub-analysis focusing on outcomes and research questionsSemantic proximity Read

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort StudySemantic proximity Read

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.Semantic proximity Read

Understanding antidepressant change patterns in the UK BiobankSemantic proximity Read

Common and rare variant contributions to discontinuation of stimulant treatment in ADHD.Semantic proximity Read

Prediction of antidepressant side effects in the Genetic Link to Anxiety and Depression StudySemantic proximity Read

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.Semantic proximity Read

Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.Semantic proximity Read

Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment.Semantic proximity Read

Association of Atomoxetine Discontinuation Patterns with CYP2D6 Phenotype in Children and Adolescents with Attention Deficit Hyperactivity Disorder.Semantic proximity Read